PS Targeting is HUGE ...is that not why Joseph Carleone was brought on board as Chair?
I didn't realize the patent was published with Kathryn Packman ...and others including Kelli J Glenn at SK Holdings
Some reading for the evening ....
________
PPHM - Peregrine Pharmaceuticals ...now being called Avid Bioservices CDMO had Chair of BOD Joseph Carleone and sat on AMPAC Fine Chemicals Board till August 2018 though Avid website still shows him Chair at AMPAC....which was shifted from HIG Capital to SK Holdings (which had lots of subsidiaries ...) including ties to Kelli Glenn at SK Life Sciences
___________
Joseph Carleone, Ph.D.
Chairman of the Board Dr. Carleone is Chairman of the Board of AMPAC Fine Chemicals LLC, a leading manufacturer of pharmaceutical active ingredients. .... ....
Together AMPAC Fine Chemicals (USA) and SK biotek (South Korea and Ireland) offer an expanded value proposition in the worldwide CDMO space.
.... ....
AMPAC Fine Chemicals â??AFCâ?? (recently acquired by SK Holdings) and SK biotek now offer expanded CDMO services across three continents, and with six manufacturing sites and one dedicated Analytical Testing facility, offer comprehensive capabilities that support all phases of drug development and commercialization.
About Toxicology, DMPK, and Bioanalytical department head who leads a group of dedicated scientists in developing drugs from Phase I through post-market. DMPK and bioanalytical subject matter expert (SME) for all development programs within the company.
... ...
Patents
Method for administration of an anti tumor agent
Issued September 26, 2013 United StatesWO2013139687 A1
There is provided a new pharmaceutical product comprising Compound (A) characterized by a dosage regimen which maximizes anti-tumor activity while maintaining acceptable toxicity levels. There is provided a new pharmaceutical product comprising Compound (A) characterized by a dosage regimen which maximizes anti-tumor activity while maintaining acceptable toxicity levels.
Patents by Inventor Kathryn Packman Kathryn Packman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
METHOD FOR ADMINISTRATION Publication number: 20190328708
Abstract: There is provided a new dosage regimen for Compound A which maximizes anti-tumor activity while maintaining acceptable toxicity levels.
Type: Application Filed: July 12, 2019 Publication date: October 31, 2019
Inventors:
Kelli Glenn, Brian Higgins, Gwen Nichols, Kathryn Packman